Trial intelligence / Profile preview

US-Guided SAP Block vs Dexmedetomidine for Rib Fracture Pain

NCT05965895Phase 4Unknown

Sponsor
Beni Suef University
Start
Aug 2023
Primary completion
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of levobupivacaine and dexmedetomidine in pain (2 arms), sponsored by Beni Suef University. Primary endpoint: Visual Analogue Scale for Pain at 48 hours. Status: unknown.

02

Drugs

levobupivacainedexmedetomidine
03

Conditions

pain

Beyond the preview

Go deeper on NCT05965895.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05965895.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call